Lee Cronin's The Mummy, a Blumhouse and Atomic Monster supernatural horror reimagining produced by James Wan and Jason Blum, builds intense anticipation ahead of its April 17 theatrical release following a Los Angeles premiere on April 9. Early reactions from screenings praise its gore-heavy body horror and mean-spirited scares reminiscent of Cronin's Certified Fresh Evil Dead Rise (84% Tomatometer), positioning it as a potential genre standout despite notes on its lengthy runtime. With no Rotten Tomatoes score yet amid zero reviews, trader consensus hinges on imminent critic verdicts post-embargo, influenced by the director's rising profile, visceral trailers, and recent interviews unveiling fresh mummification terrors. Watch for first-wave reviews from major outlets and box office tracking, as spring competition and audience scores could sway the final Tomatometer.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated"Lee Cronin's The Mummy" Rotten Tomatoes score?
"Lee Cronin's The Mummy" Rotten Tomatoes score?
55+
80%
60+
58%
65+
58%
70+
52%
75+
30%
80+
27%
85+
15%
$659 Vol.
55+
80%
60+
58%
65+
58%
70+
52%
75+
30%
80+
27%
85+
15%
If, for any reason, the resolution data is unavailable at this market's specified end time, the resolution source will be checked until the relevant data is available. This market will resolve to “No” if no data is available by April 24, 2026, 11:59 PM ET.
Market Opened: Apr 14, 2026, 6:05 PM ET
Resolver
0x65070BE91...If, for any reason, the resolution data is unavailable at this market's specified end time, the resolution source will be checked until the relevant data is available. This market will resolve to “No” if no data is available by April 24, 2026, 11:59 PM ET.
Resolver
0x65070BE91...Lee Cronin's The Mummy, a Blumhouse and Atomic Monster supernatural horror reimagining produced by James Wan and Jason Blum, builds intense anticipation ahead of its April 17 theatrical release following a Los Angeles premiere on April 9. Early reactions from screenings praise its gore-heavy body horror and mean-spirited scares reminiscent of Cronin's Certified Fresh Evil Dead Rise (84% Tomatometer), positioning it as a potential genre standout despite notes on its lengthy runtime. With no Rotten Tomatoes score yet amid zero reviews, trader consensus hinges on imminent critic verdicts post-embargo, influenced by the director's rising profile, visceral trailers, and recent interviews unveiling fresh mummification terrors. Watch for first-wave reviews from major outlets and box office tracking, as spring competition and audience scores could sway the final Tomatometer.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated

Beware of external links.
Beware of external links.
Frequently Asked Questions